VT00123 (S-enantiomer) for COVID-19

 VT00123 (S-enantiomer) has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 200+ treatments. We have not reviewed VT00123 (S-enantiomer) in detail.
unknown, u., Structural basis for small molecule binding to the SARS-CoV-2 nsp10–nsp14 ExoN complex, Nucleic Acids Research, doi:10.1093/nar/gkaf753